Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.44 USD | +1.50% | +1.78% | -24.85% |
Apr. 04 | British billionaire Joe Lewis fined $5 million by US judge for insider trading | RE |
Apr. 04 | Multibillionaire Joe Lewis to face US sentencing for insider trading | RE |
Valuation
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Capitalization 1 | - | 957.8 | 639.3 | 1,010 | 794.1 | - | - |
Enterprise Value (EV) 1 | - | 816.5 | 579.3 | 943.3 | 815.8 | 541.8 | 437.6 |
P/E ratio | -2.53 x | -11.6 x | -5.89 x | -9.17 x | -5.8 x | -5.55 x | -4.92 x |
Yield | - | - | - | - | - | - | - |
Capitalization / Revenue | - | 25.9 x | 25.7 x | 27.6 x | 25.9 x | 24 x | 23.5 x |
EV / Revenue | - | 22 x | 23.3 x | 25.8 x | 26.6 x | 16.4 x | 12.9 x |
EV / EBITDA | - | -14.3 x | -5.29 x | -8.44 x | -5.39 x | -3 x | -2.14 x |
EV / FCF | - | - | - | -7.89 x | -6.37 x | -3.87 x | -2.81 x |
FCF Yield | - | - | - | -12.7% | -15.7% | -25.8% | -35.5% |
Price to Book | - | - | - | - | - | - | - |
Nbr of stocks (in thousands) | - | 87,546 | 88,177 | 101,990 | 106,735 | - | - |
Reference price 2 | 11.44 | 10.94 | 7.250 | 9.900 | 7.440 | 7.440 | 7.440 |
Announcement Date | 4/20/21 | 3/28/22 | 3/27/23 | 3/18/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net sales 1 | - | 37.04 | 24.86 | 36.53 | 30.68 | 33.07 | 33.8 |
EBITDA 1 | - | -57.29 | -109.5 | -111.8 | -151.4 | -180.8 | -204.7 |
EBIT 1 | - | -58.19 | -111.1 | -114.2 | -142.2 | -163.9 | -191.1 |
Operating Margin | - | -157.09% | -446.79% | -312.57% | -463.4% | -495.44% | -565.39% |
Earnings before Tax (EBT) 1 | - | -57.94 | -108.1 | -101.6 | -132.7 | -151.3 | -172.4 |
Net income 1 | -51.97 | -58.24 | -108.2 | -101.7 | -132.1 | -151.6 | -177.4 |
Net margin | - | -157.21% | -435.14% | -278.54% | -430.68% | -458.51% | -524.81% |
EPS 2 | -4.530 | -0.9400 | -1.230 | -1.080 | -1.283 | -1.342 | -1.512 |
Free Cash Flow 1 | - | - | - | -119.5 | -128 | -140 | -155.5 |
FCF margin | - | - | - | -327.18% | -417.25% | -423.3% | -460.05% |
FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - |
Announcement Date | 4/20/21 | 3/28/22 | 3/27/23 | 3/18/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 6.787 | 5.716 | 5.758 | 5.771 | 6.92 | 6.411 | 5.766 | 14.6 | 10.73 | 5.431 | 7.505 | 7.836 | 7.668 | 7.693 | 6.25 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBIT 1 | -19.57 | -21.98 | -25.38 | -25.2 | -29.92 | -30.57 | -30.29 | -23.25 | -25.63 | -35.01 | -32.86 | -34.37 | -35.9 | -38.61 | -34.75 |
Operating Margin | -288.33% | -384.6% | -440.76% | -436.7% | -432.41% | -476.79% | -525.25% | -159.25% | -238.78% | -644.69% | -437.85% | -438.6% | -468.15% | -501.84% | -556% |
Earnings before Tax (EBT) 1 | -19.53 | -21.87 | -25.21 | -24.86 | -29.05 | -29.01 | -28.01 | -20.65 | -22.24 | -30.72 | -31.39 | -32.48 | -33.53 | -35.35 | -33.51 |
Net income 1 | -19.59 | -22.05 | -25.21 | -24.86 | -29.05 | -29.06 | -28.01 | -20.71 | -22.26 | -30.76 | -31.46 | -32.37 | -33.34 | -34.97 | -33.51 |
Net margin | -288.64% | -385.69% | -437.79% | -430.74% | -419.8% | -453.28% | -485.74% | -141.87% | -207.45% | -566.43% | -419.19% | -413.07% | -434.77% | -454.54% | -536.14% |
EPS 2 | -0.2800 | -0.2600 | -0.2900 | -0.2800 | -0.3300 | -0.3300 | -0.3200 | -0.2300 | -0.2300 | -0.3000 | -0.3129 | -0.3200 | -0.3214 | -0.3314 | -0.3200 |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 11/9/21 | 3/28/22 | 5/11/22 | 8/10/22 | 11/10/22 | 3/27/23 | 5/9/23 | 8/7/23 | 11/8/23 | 3/18/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | 21.7 | - | - |
Net Cash position 1 | - | 141 | 60 | 66.4 | - | 252 | 357 |
Leverage (Debt/EBITDA) | - | - | - | - | -0.1434 x | - | - |
Free Cash Flow 1 | - | - | - | -120 | -128 | -140 | -156 |
ROE (net income / shareholders' equity) | - | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - | - |
Capex 1 | - | - | 7.69 | 1.53 | 3.65 | 4.2 | 5.1 |
Capex / Sales | - | - | 30.94% | 4.18% | 11.9% | 12.7% | 15.09% |
Announcement Date | 4/20/21 | 3/28/22 | 3/27/23 | 3/18/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.85% | 794M | |
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- TNGX Stock
- Financials Tango Therapeutics, Inc.